HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) major shareholder Of America Corp /De/ Bank sold 412 shares of the firm’s stock in a transaction on Tuesday, April 3rd. The shares were sold at an average price of $26.83, for a total value of $11,053.96. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.
HCA Healthcare Stock Performance
HCA opened at $342.25 on Friday. The firm has a market capitalization of $84.26 billion, a PE ratio of 15.58, a P/E/G ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The firm has a 50 day moving average of $324.53 and a two-hundred day moving average of $341.25. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the company posted $5.90 earnings per share. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.
HCA Healthcare Increases Dividend
Analysts Set New Price Targets
HCA has been the subject of several research reports. Truist Financial lowered their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Morgan Stanley dropped their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a research report on Monday, January 27th. KeyCorp decreased their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a report on Tuesday, December 17th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $385.67.
Check Out Our Latest Stock Report on HCA Healthcare
Hedge Funds Weigh In On HCA Healthcare
A number of hedge funds have recently bought and sold shares of HCA. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth approximately $31,000. Tidemark LLC purchased a new position in HCA Healthcare during the fourth quarter valued at $36,000. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare during the third quarter worth about $39,000. Activest Wealth Management lifted its stake in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after buying an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. increased its stake in HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after buying an additional 50 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Further Reading
- Five stocks we like better than HCA Healthcare
- Learn Technical Analysis Skills to Master the Stock Market
- MarketBeat Week in Review – 03/24 – 03/28
- ETF Screener: Uses and Step-by-Step Guide
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Trading Halts Explained
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.